Statistics

Total Visits

Views
IL28B-based model for prediction of early response in patients with hepatitis C genotype 1&4 treated with peginterferon alfa 2a plus ribavirin (P plus R). OPTIM study26

Select a period of time:

Number of views in the range

Views
IL28B-based model for prediction of early response in patients with hepatitis C genotype 1&4 treated with peginterferon alfa 2a plus ribavirin (P plus R). OPTIM study17

Views

Views
October 20241
November 20240
December 20241
January 20250
February 20250
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United Kingdom1
United States1
 

Top cities views

Views
Los Angeles1